Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

The following highlights spotlight the latest advances in gastroenterology, featuring studies and insights presented at this ...

A clinical trial delivering hope to people living with inflammatory bowel disease (IBD) has reached an important milestone, with initial results ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Women with inflammatory bowel disease (IBD) are three times more likely to forgo having children than people without the ...

Move over, colonoscopies - researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.

Swapping colonoscopies for swallowing a pill packed with bacteria that can read the condition of our gut could revolutionize ...

The specialized Pregnancy & Pre-conception Inflammatory Bowel Disease Clinic is the first of its kind in Chicago and one of a ...